Back to search results

Broccoli Microgreens for Obese Breast Cancer Survivors

This study is looking at whether eating broccoli microgreens (BMG) can be a helpful part of the diet for obese breast cancer survivors. Obesity can increase the risk of cancer returning, and BMG are young broccoli plants packed with nutrients that may help. Researchers will ask 24 obese women who have survived breast cancer to eat one cup (about 57 grams) of raw BMG every day for two weeks. The main goals are to see if it's practical for people to stick to this diet and if they actually do it. This study is currently unclear about its recruitment status.

Study design
This is a single-arm study, meaning all 24 participants will receive the same intervention. It is a pilot study, which means it's an early look at the intervention.
What's involved
You would eat one cup of raw broccoli microgreens daily for two weeks. Biological samples like blood and stool, along with questionnaires, will be collected at the beginning and end of the two weeks.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 14 days, which is the duration of the intervention and when the primary endpoints are measured.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07032545

Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors

Recruiting
NAAll AgesInterventionalSupportive care
University of Maryland, Baltimore
~24 participants
Updated 2025-12-23 on ClinicalTrials.gov
What's tested:Broccoli microgreen (BMG)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility, as Assessed by the Percentage of Participants Who Enrolled and Completed the Study
Measured over 14 days
+1 more outcome measured

Conditions

Obesity and Overweight
Breast Cancer Survivorship

Explore related trials

Breast CarcinomaObesity

Where it's being run

1 sites across 1 states
Maryland1

Study leadership

  • Yuanyuan (Rose) Li, M.D., Ph.D. · PRINCIPAL_INVESTIGATOR · University of Maryland

Who to contact

Yuanyuan (Rose) Li, M.D., Ph.D.
[email protected]
13014050776
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Female
Had a diagnosis of breast cancer (Stage I-III)
2 to 60 months post-curative treatment (surgery, chemotherapy, and/or radiation)
BMI \> 30 kg/m² (obese classification)
Willing to avoid cruciferous vegetables during the study
Able to sign an IRB-approved consent form

Exclusion

Have any contraindications to the proposed nutrition intervention as identified by their medical provider, their designee, or the study team (e.g., GI conditions, medication requirements, pregnancy, breastfeeding, recent history of an eating disorder).
Allergy or intolerance to cruciferous vegetables
Currently taking broccoli extract supplements

What this trial measures

  • Feasibility, as Assessed by the Percentage of Participants Who Enrolled and Completed the Study14 days

    Feasibility will be assessed by calculating the percentage of participants who enrolled and completed the study by providing evaluable data at baseline, during the BMG intervention and after 2-weeks treatment.

  • Compliance, as Assessed by the Percentage of the Participants Who Adhere to the Assigned BMG Intervention14 days

    Compliance will be assessed by measuring the percent of the participants who consume the assigned BMG through the recommended cooking method during the 2-weeks of intervention period.